Key Takeaways
- Mozza Foods plans to launch dairy proteins derived from soybeans by late 2028, pending regulatory approvals.
- The startup emphasizes cost-effective production using existing agricultural infrastructure instead of expensive biomanufacturing systems.
- Significant progress has been made with current expression levels of casein proteins in soybeans, aimed at reaching 7g per 100g by the end of 2023.
Mozza Foods Targets Dairy Protein Production from Soybeans
California-based Mozza Foods is focused on launching its first dairy proteins sourced from soybeans by late 2028, awaiting approvals from the USDA and FDA. Unlike early market entrants driven by venture capital to quickly produce consumer goods, Mozza’s approach is business-to-business (B2B), recognizing the time needed for product development.
Co-founder and CEO Adam Tarshis states that dairy buyers prioritize cost and reliable supply over environmental and animal welfare factors. To address these needs, Mozza has directed its efforts toward enhancing the expression levels of casein proteins in soybeans and utilizing existing dairy processing infrastructure. The firm has conducted three years of field trials across multiple states, targeting 7g of casein protein per 100g of soybeans by year-end; currently, they are at 4g, increasing expression levels by 100% annually.
Tarshis highlights a fundamental economic advantage for molecular farming over precision fermentation: lower capital and operational expenditures. By growing and processing soybeans, Mozza avoids the hefty costs associated with precision fermentation systems. The firm’s strategy allows for easier scaling, primarily by distributing more seeds and increasing farmland.
Mozza’s unique approach in producing casein micelles directly within soybeans allows for a more efficient extraction process. This structure provides the desired functionality for commercial applications and simplifies downstream processing. Currently, the company can produce three out of four key casein proteins, with research indicating that alpha S2 is not essential.
In addition to protein extraction, Mozza aims to maximize all components of the soybean. The oil remains market-ready as it contains no casein, and the remaining soy protein can still enter animal feed, benefiting from its protein quality. The firm is leveraging its production capabilities to develop a co-product strategy that could enhance profitability.
Mozza has implemented an identity preservation system called Grain Track, which ensures the traceability of crops throughout the supply chain. This effort addresses regulatory requirements and assures customers of product integrity. By maintaining crop segregation from the commodity supply chain, Mozza enhances its operational reliability.
The startup has secured approximately $24 million in funding and is engaging with both USDA and FDA regarding regulatory submissions. Tarshis anticipates USDA approval for growing their modified seeds soon, followed by GRAS submissions to the FDA.
As interest in alternative protein sources grows, Mozza is fostering relationships with major dairy manufacturers in the U.S. and Europe while expanding its reach into Asia. The company is currently working to raise an additional $4 million to ensure cost competitiveness. Tarshis acknowledges the investment challenges within the industry but stresses the importance of developing scalable technologies that don’t heavily rely on government funding.
Molecular farming, defined as genetically engineering plants to produce valuable compounds, has garnered attention as a sustainable alternative to traditional animal agriculture. Companies like Mozza Foods and several others are paving the way for the future of protein production, which aims for efficiency and ethical considerations in food systems.
The content above is a summary. For more details, see the source article.
